Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT00724360
Eligibility Criteria:
Inclusion Criteria:
* age \> 18 years
* B-ALL in relapse
* refractory B-ALL-performance status of 0-2 on the Eastern Cooperative Oncology Group scale
* adequate hepatic and renal functions (AST or ALT \<= 5 times the upper limit of normal creatinine \< 2 times the upper limit of normal)
* \> 20% blasts in bone marrow,
* \> 30% of bone marrow blast population HER2 positive as assessed by immunophenotyping
Exclusion Criteria:
* Previous treatment by trastuzumab
* FEVG \< 50%
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00724360
Study Brief:
Protocol Section:
NCT00724360